Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 214

    1.

    Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy.

    Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Oshima Y, Kamei M, Tano Y.

    Br J Ophthalmol. 2008 Jan;92(1):70-3. Epub 2007 Jun 13.PMID: 17567661 [PubMed - indexed for MEDLINE]Related articles

    2.

    Treatment of choroidal neovascularization using intravitreal bevacizumab.

    Pedersen R, Soliman W, Lund-Andersen H, Larsen M.

    Acta Ophthalmol Scand. 2007 Aug;85(5):526-33. Epub 2007 May 18.PMID: 17511757 [PubMed - indexed for MEDLINE]Related articles

    3.

    The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy.

    Lee SY, Kim JG, Joe SG, Chung H, Yoon YH.

    Korean J Ophthalmol. 2008 Jun;22(2):92-9.PMID: 18612226 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.

    Chan WM, Lai TY, Liu DT, Lam DS.

    Ophthalmology. 2007 Dec;114(12):2190-6. Epub 2007 Jun 28.PMID: 17599414 [PubMed - indexed for MEDLINE]Related articles

    5.

    Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy.

    Lai TY, Chan WM, Liu DT, Luk FO, Lam DS.

    Br J Ophthalmol. 2008 May;92(5):661-6. Epub 2008 Mar 20.PMID: 18356265 [PubMed - indexed for MEDLINE]Related articles

    6.

    Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration.

    Bashshur ZF, Bazarbachi A, Schakal A, Haddad ZA, El Haibi CP, Noureddin BN.

    Am J Ophthalmol. 2006 Jul;142(1):1-9.PMID: 16815245 [PubMed - indexed for MEDLINE]Related articles

    7.

    Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.

    Ladas ID, Kotsolis AI, Papakostas TD, Rouvas AA, Karagiannis DA, Vergados I.

    Retina. 2007 Sep;27(7):891-6.PMID: 17891013 [PubMed - indexed for MEDLINE]Related articles

    8.

    Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

    Retina. 2007 Apr-May;27(4):432-8.PMID: 17420694 [PubMed - indexed for MEDLINE]Related articles

    9.

    Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results.

    Gharbiya M, Allievi F, Mazzeo L, Gabrieli CB.

    Am J Ophthalmol. 2009 Jan;147(1):84-93.e1. Epub 2008 Sep 6.PMID: 18774547 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization.

    Mandal S, Garg S, Venkatesh P, Mithal C, Vohra R, Mehrotra A.

    Arch Ophthalmol. 2007 Nov;125(11):1487-92.PMID: 17998509 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Intravitreal bevacizumab in inflammatory ocular neovascularization.

    Mansour AM, Mackensen F, Arevalo JF, Ziemssen F, Mahendradas P, Mehio-Sibai A, Hrisomalos N, Lai TY, Dodwell D, Chan WM, Ness T, Banker AS, Pai SA, Berrocal MH, Tohme R, Heiligenhaus A, Bashshur ZF, Khairallah M, Salem KM, Hrisomalos FN, Wood MH, Heriot W, Adan A, Kumar A, Lim L, Hall A, Becker M.

    Am J Ophthalmol. 2008 Sep;146(3):410-416. Epub 2008 Jul 10.PMID: 18619571 [PubMed - indexed for MEDLINE]Related articles

    12.

    Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks.

    Sawa M, Gomi F, Tsujikawa M, Sakaguchi H, Tano Y.

    Am J Ophthalmol. 2009 Oct;148(4):584-590.e2. Epub 2009 Jul 9.PMID: 19541288 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results.

    Ikuno Y, Sayanagi K, Soga K, Sawa M, Tsujikawa M, Gomi F, Tano Y.

    Am J Ophthalmol. 2009 Jan;147(1):94-100.e1. Epub 2008 Sep 6.PMID: 18774550 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.

    Chan WM, Lai TY, Liu DT, Lam DS.

    Am J Ophthalmol. 2007 Jun;143(6):977-983. Epub 2007 Apr 24.PMID: 17459318 [PubMed - indexed for MEDLINE]Related articles

    15.

    Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization.

    Mandal S, Venkatesh P, Sampangi R, Garg S.

    Eur J Ophthalmol. 2007 Jul-Aug;17(4):620-6.PMID: 17671940 [PubMed - indexed for MEDLINE]Related articles

    16.

    Long-term visual outcomes of intravitreal bevacizumab in inflammatory ocular neovascularization.

    Mansour AM, Arevalo JF, Ziemssen F, Mehio-Sibai A, Mackensen F, Adan A, Chan WM, Ness T, Banker AS, Dodwell D, Chau Tran TH, Fardeau C, Lehoang P, Mahendradas P, Berrocal M, Tabbarah Z, Hrisomalos N, Hrisomalos F, Al-Salem K, Guthoff R.

    Am J Ophthalmol. 2009 Aug;148(2):310-316.e2. Epub 2009 May 9.PMID: 19427992 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intravitreal bevacizumab therapy for choroidal neovascularization secondary to age-related macular degeneration: 6-month results of an open-label uncontrolled clinical study.

    Giansanti F, Virgili G, Bini A, Rapizzi E, Giacomelli G, Donati MC, Verdina T, Menchini U.

    Eur J Ophthalmol. 2007 Mar-Apr;17(2):230-7.PMID: 17415697 [PubMed - indexed for MEDLINE]Related articles

    18.

    Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia.

    Hernández-Rojas ML, Quiroz-Mercado H, Dalma-Weiszhausz J, Fromow-Guerra J, Amaya-Espinosa A, Solís-Vivanco A, Reyna-Castelán E, Abraham-Marín M, Martínez-Castellanos MA, Aiello LP.

    Retina. 2007 Jul-Aug;27(6):707-12.PMID: 17621179 [PubMed - indexed for MEDLINE]Related articles

    19.

    Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia.

    Sakaguchi H, Ikuno Y, Gomi F, Kamei M, Sawa M, Tsujikawa M, Oshima Y, Kusaka S, Tano Y.

    Br J Ophthalmol. 2007 Feb;91(2):161-5. Epub 2006 Aug 16.PMID: 16914470 [PubMed - indexed for MEDLINE]Related articles

    20.

    Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.

    Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT, Emerson GG, Schlesinger TK, Nolte SK, Klein ML.

    Retina. 2007 Apr-May;27(4):439-44.PMID: 17420695 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data